For the quarter ending 2026-03-31, GDRX has $2,021,251K in assets. $1,399,265K in debts. $235,710K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 235,710 | 261,820 | 273,529 | 281,318 |
| Accounts receivable, net | 232,721 | 235,746 | 203,738 | 189,027 |
| Prescription reimbursement assets | 753,530 | 98,331 | - | - |
| Prepaid expenses and other current assets | 44,507 | 47,205 | 88,248 | 80,269 |
| Total current assets | 1,266,468 | 643,102 | 565,515 | 550,614 |
| Property and equipment, net | 11,742 | 12,268 | 11,276 | 10,732 |
| Goodwill | 430,331 | 430,331 | 421,719 | 421,719 |
| Intangible assets, net | 61,167 | 64,082 | 62,773 | 65,566 |
| Capitalized software, net | 140,191 | 139,261 | 142,118 | 138,287 |
| Operating lease right-of-use assets, net | 28,748 | 28,808 | 29,694 | 30,692 |
| Deferred tax assets, net | 53,042 | 57,111 | 69,093 | 77,182 |
| Other assets | 29,562 | 29,095 | 23,319 | 23,914 |
| Total assets | 2,021,251 | 1,404,058 | 1,325,507 | 1,318,706 |
| Accounts payable | 14,525 | 19,405 | 28,725 | 25,411 |
| Prescription reimbursement liabilities | 750,978 | 130,139 | - | - |
| Accrued expenses and other current liabilities | 83,719 | 86,705 | 143,372 | 95,677 |
| Current portion of debt | 5,000 | 5,000 | 5,000 | 5,000 |
| Operating lease liabilities, current | 4,976 | 4,753 | 4,761 | 4,821 |
| Total current liabilities | 859,198 | 246,002 | 181,858 | 130,909 |
| Debt, net | 482,422 | 483,264 | 484,114 | 484,972 |
| Operating lease liabilities, net of current portion | 48,953 | 49,789 | 51,260 | 52,745 |
| Other liabilities | 8,692 | 8,741 | 7,563 | 7,049 |
| Total liabilities | 1,399,265 | 787,796 | 724,795 | 675,675 |
| Common stock, 0.0001 par value class a 2,000,000 shares authorized, 103,613 and 107,088 shares issued and outstanding at march31, 2026 and december31, 2025, respectively and class b 1,000,000 shares authorized, 233,964 shares issued and outstanding at march31, 2026 and december31, 2025 | 34 | 34 | 34 | 35 |
| Additional paid-in capital | 2,031,357 | 2,026,802 | 2,016,677 | 2,060,114 |
| Accumulated deficit | -1,409,405 | -1,410,574 | -1,415,999 | -1,417,118 |
| Total stockholders' equity | 621,986 | 616,262 | 600,712 | 643,031 |
| Total liabilities and stockholders' equity | 2,021,251 | 1,404,058 | 1,325,507 | 1,318,706 |
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)